Teva's U.S. Unit Charged in Generic-Drug Price-Fixing Probe - Bloomberg
Meet the Women of Bloomberg TV
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Watch Teva to Make Fewer Generic Drugs - Bloomberg
Jana Partners Takes New Stake in Teva, Cheering Cost-Cut Plans - Bloomberg
Teva Seeking to Break Its Streak of Post-Earnings Stock Losses - Bloomberg
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Lifts Outlook With Drug Production Mostly Unaffected by War - Bloomberg
Teva: Warren Buffett Messed Things Up For Short-Sellers - Bloomberg
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
U.S. charges Teva in generic drugs price-fixing probe
Teva (TEVA), AbbVie (ABBV) to Pay $161.5 Million in West Virginia Opioid Case - Bloomberg
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state | CNN
Teva Considers 10,000 Job Cuts - Bloomberg
Teva's job-cut tally could touch 10K: report | Fierce Pharma
Teva (TEVA) Explores Sale of $2 Billion Active Ingredients Unit - Bloomberg
Teva considering sale of inflammatory bowel disease asset | Seeking Alpha
Teva's Links to Opioid Epidemic May Triple Funding Costs - Bloomberg
Teva Pharmaceutical Industries
